Comparison of Bevacizumab Quantification Results in Plasma of Non-small Cell Lung Cancer Patients Using Bioanalytical Techniques Between LC-MS/MS, ELISA, and Microfluidic-based Immunoassay-Reference-Cited by-同舟云学术

Comparison of Bevacizumab Quantification Results in Plasma of Non-small Cell Lung Cancer Patients Using Bioanalytical Techniques Between LC-MS/MS, ELISA, and Microfluidic-based Immunoassay

Published:2019-08-20 Issue:6 Volume:21 Page:
ISSN:1550-7416
Container-title:The AAPS Journal
language:en
Short-container-title:AAPS J

Author:

Iwamoto Noriko,Takanashi Megumi,Shimada Takashi,Sasaki Jiichiro,Hamada Akinobu

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/content/pdf/10.1208/s12248-019-0369-z.pdf

Reference26 articles.

1. Chen SC, Quartino A, Polhamus D, Riggs M, French J, Wang X, et al. Population pharmacokinetics and exposure-response of trastuzumab emtansine in advanced breast cancer previously treated with >/=2 HER2-targeted regimens. Br J Clin Pharmacol. 2017;83(12):2767–77. https://doi.org/10.1111/bcp.13381 .

2. Geukes Foppen MH, Rozeman EA, van Wilpe S, Postma C, Snaebjornsson P, van Thienen JV, et al. Immune checkpoint inhibition-related colitis: symptoms, endoscopic features, histology and response to management. ESMO Open. 2018;3(1):e000278. https://doi.org/10.1136/esmoopen-2017-000278 .

3. Nishidate M, Hayashi M, Aikawa H, Tanaka K, Nakada N, Miura SI, et al. Applications of MALDI mass spectrometry imaging for pharmacokinetic studies during drug development. Drug Metab Pharmacokinet. 2019;34:209–16. https://doi.org/10.1016/j.dmpk.2019.04.006 .

4. Liu X, Lukowski JK, Flinders C, Kim S, Georgiadis RA, Mumenthaler SM, et al. MALDI-MSI of immunotherapy: mapping the EGFR-targeting antibody Cetuximab in 3D colon-cancer cell cultures. Anal Chem. 2018;90(24):14156–64. https://doi.org/10.1021/acs.analchem.8b02151.

5. Randall EC, Emdal KB, Laramy JK, Kim M, Roos A, Calligaris D, et al. Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma. Nat Commun. 2018;9(1):4904. https://doi.org/10.1038/s41467-018-07334-3 .

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A sensitive analytical strategy of oligonucleotide functionalized fluorescent probes for detection of nusinersen sodium in human serum;Talanta;2024-08

2. Synthesis and electrochemical study of enzymatic graphene oxide-based nanocomposite as stable biosensor for determination of bevacizumab as a medicine in colorectal cancer in human serum and wastewater fluids;Chemosphere;2023-09

3. High‐throughput untargeted screening of biotherapeutic macromolecules in equine plasma by UHPLC‐HRMS/MS: Application to monoclonal antibodies and Fc‐fusion proteins for doping control;Drug Testing and Analysis;2023-06-20

4. Studying the pharmacokinetics of biotechnological medicinal products on the example of monoclonal antibodies;Biological Products. Prevention, Diagnosis, Treatment;2023-05-03

5. An Update on Recently Developed Analytical and Bio-analytical Methods for Some Anticancer Drugs;Current Pharmaceutical Analysis;2023-02